Re: GYN: Endometrial cells on pap

From: Braun, R. Daniel (rbraun@iupui.edu)
Wed Oct 1 14:10:56 2003


Why did those 61 have histologic follow up? Because they were bleeding??????? Maybe????

If not an inclusional bias of this nature, then around 35 of the 160 who had no histologic follow up would have also had endometrial cancer. I would hope that at lest afew of those would have showed up back at the same institution and hence detected.

Dan

-----Original Message----- From: art fougner, md [mailto:evsono@pipeline.com] Sent: Wednesday, October 01, 2003 10:53 AM To: Multiple recipients of list OB-GYN-L Subject: Re: GYN: Endometrial cells on pap

But see:

J Reprod Med. 2001 Sep;46(9):795-8.

Significance of benign endometrial cells in Pap smears from postmenopausal women.

Wu HH, Schuetz MJ 3rd, Cramer H.

Department of Pathology, Ball Memorial Hospital, 2401 University Avenue, Muncie, IN 47303, USA. wuh@palab.com

OBJECTIVE: To assess the significance of benign exfoliated endometrial epithelial or stromal cells on cervicovaginal Pap smears obtained from postmenopausal women not receiving exogenous hormones. STUDY DESIGN: A computerized search of the cytology database at two institutions was performed for a five-year period, and all cervical cytology cases from postmenopausal patients diagnosed with benign endometrial cells were identified. Those cases with histologic follow-up within 12 months of the original cytologic evaluation were selected for analysis, and their cytology and surgical pathology slides were reviewed. RESULTS: A total of 227 postmenopausal women with benign endometrial cells were identified. Of the 61 patients with histologic follow-up, 25 (41%) had significant endometrial diseases, including hyperplasia without atypia (11), atypical endometrial hyperplasia (5), well-differentiated adenocarcinoma (8) and high grade serous carcinoma (1). Benign diagnoses, including atrophy (15), weakly proliferative endometrium (9) and proliferative endometrium (6), were noted in 30 patients (49%). Endometrial polyp was identified in three patients (5%). There were three cases of nondiagnostic histologic specimens that lacked endometrial tissue (5%). Two of nine women (22%) with proven carcinoma were asymptomatic. CONCLUSION: The diagnosis of endometrial cells, cytologically benign, in a postmenopausal woman not receiving hormone on Pap smears is associated with a significant number of cases of endometrial hyperplasia, atypical hyperplasia and carcinoma.

art

At Tue, 30 Sep 2003, Dr. Ainsworth wrote: >
>Carmen R. Gomez-Fernandez, MD, Parvin Ganjei-Azar, MD, Katayoon
>Behshid, MD, Hervy E. Averette, MD, and Mehrdad Nadji, MD. Normal
>Endometrial Cells in Papanicolaou Smears: Prevalence in Women With and
>Without Endometrial Disease Obstetrics & Gynecology, December 2000,
>Volume 96, Number 6, Pages 874 - 878.
>
>Normal endometrial cells were present in the Papanicolaou smears of few
>women: 2% of those with endometrial hyperplasia or carcinoma and 5% of
>those without significant endometrial disease. Abnormal vaginal
>bleeding was the reason for further evaluation of these patients. The
>prevalence of normal endometrial cells did not differ significantly
>between the two groups of patients, therefore there was no evidence
>that the presence of these cells in Papanicolaou smears was indicative
>of an increased likelihood of endometrial hyperplasia or carcinoma.
>Our series was large, and we had 80% power to detect a meaningful
>difference if one existed. In no study patient, postmenopausal or
>otherwise, did the presence of normal endometrial cells in Papanicolaou

>smears lead to the discovery of endometrial hyperplasia or carcinoma.
>Other studies have reported similar findings.
>
>The results of our study of 490 women demonstrate that normal
>endometrial cells are just as likely to be present in the Papanicolaou
>smears of women with benign endometrial tissue as in the smears of
>women with endometrial hyperplasia or carcinoma. The presence of
>normal endometrial cells in Papanicolaou smears, therefore, is not
>indicative of an increased likelihood of significant endometrial
>disease. These findings and those of our previous study dispute the
>recommendation of the Bethesda System to report the presence of normal
>endometrial cells in the Papanicolaou smears of postmenopausal women.
>Likewise, with regard to premenopausal women who are in the second half

>of their cycle, our data call into question the meaning of the presence

>of normal endometrial cells in Papanicoloau smears and the practice of
>reporting this cytologic finding. Instead of alerting clinicians to
>the possibility of significant endometrial disease, Papanicolaou smear
>reports of normal endometrial cells may only serve to create a
>management problem that leads to unnecessary procedures with potential
>morbidity and unjustifiable patient anxiety.
>
>>52 YO postmenopausal woman, not on HRT, no bleeding, has endometrial
>>cells on her pap.
>>
>>Would you:
>>
>>1. Do nothing?
>>2. Endo biopsy/ECC?
>>3. Ultrasound for endometrial thickness?
>>4. Other?
>>
>>Garry
>>
>>--
>>Garry E. Siegel, M.D.
>>Private Practice
>>Roswell, GA
>>

--
art fougner, md
ich bin ein New Yorker




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Jul 2 04:36:14 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.